Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06378138
Status:
RECRUITING
Last Update Posted:
2024-04-22
First Post:
2024-04-06
Brief Title:
ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Sponsor:
Organization:
Beijing InnoCare Pharma Tech Co Ltd